BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tampaki M, Doumba PP, Deutsch M, Koskinas J. Circulating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insights. World J Hepatol 2015; 7(14): 1834-1842 [PMID: 26207165 DOI: 10.4254/wjh.v7.i14.1834]
URL: https://www.wjgnet.com/1948-5182/full/v7/i14/1834.htm
Number Citing Articles
1
M. Milovancev, D. S. Russell. Surgical margins in the veterinary cancer patientVeterinary and Comparative Oncology 2017; 15(4): 1136 doi: 10.1111/vco.12284
2
Malkhaz Mizandari, Natela Paksashvili, Nino Kikodze, Tamta Azrumelashvili, Ia Pantsulaia, Koba Shanava, Nona Janikashvili, Tinatin Chikovani. Long-Term Survival in a Patient with Low-Level Inflammatory Markers and Liver Metastasis, Converted Resectable by TACEImmunotherapy 2017; 9(13): 1067 doi: 10.2217/imt-2017-0069
3
Wan-Joon Kim, Tae-Wan Lim, Pyoung-Jae Park, Sae-Byeol Choi, Wan-Bae Kim. Prognostic markers affecting the early recurrence of hepatocellular carcinoma with liver cirrhosis after curative resectionThe International Journal of Biological Markers 2019; 34(2): 123 doi: 10.1177/1724600819834306
4
Matteo Canale, Paola Ulivi, Francesco Giuseppe Foschi, Emanuela Scarpi, Serena De Matteis, Gabriele Donati, Giorgio Ercolani, Mario Scartozzi, Luca Faloppi, Alessandro Passardi, Emiliano Tamburini, Martina Valgiusti, Giorgia Marisi, Giovanni Luca Frassineti, Andrea Casadei Gardini. Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinomaCritical Reviews in Oncology/Hematology 2018; 129: 44 doi: 10.1016/j.critrevonc.2018.06.017
5
Sophia Kästle, Matthias R. Stechele, Lisa Richter, Regina Schinner, Elif Öcal, Marianna Alunni-Fabbroni, Enrico De Toni, Stefanie Corradini, Max Seidensticker, S. Nahum Goldberg, Jens Ricke, Moritz Wildgruber, Melanie A. Kimm. Peripheral blood-based cell signature indicates response to interstitial brachytherapy in primary liver cancerJournal of Cancer Research and Clinical Oncology 2023; 149(12): 9777 doi: 10.1007/s00432-023-04875-z
6
Yang Zhao, Tongwang Yang, Yabo Ouyang, Wei Rao, Kai Liu, Jiasheng Zheng, Fudong Lv, Ying Shi, Feng Wang, Dongjie Liu, Luxin Qiao, Zhenying Xia, Yushi Zhang, Dexi Chen, Wenjing Wang. Radiofrequency ablation plays double role in immunosuppression and activation of PBMCs in recurrent hepatocellular carcinomaFrontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1339213
7
Swathi Mohankumar, Tushar Patel. Extracellular vesicle long noncoding RNA as potential biomarkers of liver cancerBriefings in Functional Genomics 2016; 15(3): 249 doi: 10.1093/bfgp/elv058
8
Cody R. Criss, Mina S. Makary. Recent Advances in Image-Guided Locoregional Therapies for Primary Liver TumorsBiology 2023; 12(7): 999 doi: 10.3390/biology12070999
9
Zhizhou Huang, Xueqiong Zhou, Yangfan He, Xiangyu Ke, Ying Wen, Fei Zou, Xuemei Chen. Hyperthermia enhances 17-DMAG efficacy in hepatocellular carcinoma cells with aggravated DNA damage and impaired G2/M transitionScientific Reports 2016; 6(1) doi: 10.1038/srep38072
10
Cheng-Shi Chen, Fang-Kun Li, Chen-Yang Guo, Jin-Cheng Xiao, Hong-Tao Hu, Hong-Tao Cheng, Lin Zheng, Deng-Wei Zong, Jun-Li Ma, Li Jiang, Hai-Liang Li. Tumor vascularity and lipiodol deposition as early radiological markers for predicting risk of disease progression in patients with unresectable hepatocellular carcinoma after transarterial chemoembolizationOncotarget 2016; 7(6): 7241 doi: 10.18632/oncotarget.6892
11
Hana Park, Jae Hyung Jung, Min Kyung Jung, Eui-Cheol Shin, Simon Weonsang Ro, Jeon Han Park, Do Young Kim, Jun Yong Park, Kwang-Hyub Han. Effects of transarterial chemoembolization on regulatory T cell and its subpopulations in patients with hepatocellular carcinomaHepatology International 2020; 14(2): 249 doi: 10.1007/s12072-020-10014-4
12
Norhanan Hamzah, Nur Karyatee Kassim, Julia Omar, Mohd Shafie Abdullah, Yeong Yeh Lee. Levels of PIVKA-II and alpha-fetoprotein in unresectable hepatocellular carcinoma compared to healthy controls and predictive values of both markers with radiological responses after loco-regional interventionsPeerJ 2023; 11: e15988 doi: 10.7717/peerj.15988
13
Changjiang Lei, Defa Ren, Meixia Fu, Chuantao Sun, Hong Ren, Qingyun Pan, Yuan Li. Curative effect of endostar combined with oxaliplatin in the treatment of primary hepatic carcinoma and its influence on immune cellsOncology Letters 2019;  doi: 10.3892/ol.2019.10022
14
Masoud Nouri‐Vaskeh, Leila Alizadeh, Khalil Hajiasgharzadeh, Ahad Mokhtarzadeh, Monireh Halimi, Behzad Baradaran. The role of HSP90 molecular chaperones in hepatocellular carcinomaJournal of Cellular Physiology 2020; 235(12): 9110 doi: 10.1002/jcp.29776
15
Anne-Laure Grindel, Nathalie Fretellier, Miguel Soares, Nabiha Bouzakher, Vincent Millot Maysounabe, Robin Santus, Olivia Bawa, Melody Wintrebert, Clémence Couquelet, Philippe Robert, Jean-Francois Emile, Claude Capron. Antitumoral effect of local injection of TLR-9 agonist emulsified in Lipiodol with systemic anti-PD-1 in a murine model of colorectal carcinomaFrontiers in Immunology 2024; 14 doi: 10.3389/fimmu.2023.1272246